Stevens D, Tallis R, Hollis S
University of Manchester, Department of Geriatric Medicine, Salford, UK.
Gerontology. 1995;41(4):220-6. doi: 10.1159/000213685.
The significance of a very elevated erythrocyte sedimentation rate (ESR) in elderly patients is debated. In a retrospective study, we searched the records of a laboratory providing the sole service to a health district for ESR measurement and identified all non-surgical and non-psychiatric patients over the age of 65 who had had an ESR above 50 mm/h. Diagnoses and mortality in a 1-year follow-up were determined from case notes. Four hundred and nine subjects (median age 75; range 65-99) were identified and data on 401 of these (155 male, 246 female; median ESR 80 mm/h, range 50-148) were adequate for 1 year follow-up. Forty-eight percent had a persistently raised ESR (two values > 50 mm/h separated by at least 14 days; group 1); 39% had a single ESR measurement only (group 2), and 13% had a transiently raised ESR (group 3). The commonest diagnosis in group 1 patients was rheumatological disease (51.8%), followed by infection (31.9%) and non-haematological malignancy (11%). Infection was the commonest diagnosis in groups 2 (47.4%) and 3 (43.7%), followed by non-haematological malignancy (19.9%) in group 2 and rheumatological disease (20.4%) in group 3. In only 1 in 20 cases was no diagnosis apparent at 1 year. The standardised mortality ratio (SMR) of the combined groups 1 and 2 (482; CI: 421-544) was strikingly raised, and even more so if patients with rheumatoid arthritis were excluded (542; CI 458-625). Where there were sufficient numbers of deaths to make SMR estimations valid, a gradient of mortality against the level of the ESR could be observed.(ABSTRACT TRUNCATED AT 250 WORDS)
老年患者红细胞沉降率(ESR)显著升高的意义存在争议。在一项回顾性研究中,我们查阅了一家为某健康区提供血沉测量唯一服务的实验室记录,确定了所有65岁以上非手术且非精神科、血沉高于50mm/h的患者。通过病例记录确定1年随访期内的诊断和死亡率。共确定了409名受试者(中位年龄75岁;范围65 - 99岁),其中401名(155名男性,246名女性;中位ESR 80mm/h,范围50 - 148)的数据足以进行1年随访。48%的患者血沉持续升高(两次测量值>50mm/h,间隔至少14天;第1组);39%的患者仅进行了一次血沉测量(第2组),13%的患者血沉短暂升高(第3组)。第1组患者最常见的诊断是风湿性疾病(51.8%),其次是感染(31.9%)和非血液系统恶性肿瘤(11%)。感染是第2组(47.4%)和第3组(43.7%)最常见的诊断,第2组其次是非血液系统恶性肿瘤(19.9%),第3组是风湿性疾病(20.4%)。仅1/20的病例在1年内未明确诊断。第1组和第2组合并组的标准化死亡比(SMR)(482;CI:421 - 544)显著升高,若排除类风湿关节炎患者则更高(542;CI 458 - 625)。在有足够死亡例数使SMR估计有效的情况下,可以观察到死亡率随ESR水平的梯度变化。(摘要截断于250字)